The Bo and Kerstin Hjelt Diabetes Foundation
The Bo & Kerstin Hjelt Diabetes Foundation was established in 2008 and is based in Switzerland. Its long-term goal is to fund research to prevent and cure type 2 diabetes.
The foundation supports research at two of Europe’s leading centers for diabetes, the University of Lund in Sweden, represented by Prof. Leif Groop and the University of Geneva in Switzerland, represented by Prof. Claes Wollheim. Professor Leif Groop is Co-ordinator for the Diabetes Centre at the University of Lund and Professor Claes Wollheim is a member of the Scientific Committee.
Bo and Kerstin Hjelt have dedicated a significant sum of money and time to develop the foundation’s resources and increase its capital base. Financially the basis of the Foundation is provided by a donation made by Bo and Kerstin Hjelt in 2008. It is planned to increase the capital through fund raising.
Diabetes is a chronic disease, characterized by an excess of sugar in the blood. It is caused by an insufficient production, and impaired action of insulin regulating the level of sugar in the blood. The worldwide increase in the incidence of type 2 diabetes is reaching frightening proportions. International studies show that we can expect a 40% increase in type 2 diabetes within the next 25-30 years.
Bo Hjelt is suffering from type 2 diabetes (T2D) since the mid 1990’s, requiring 5 daily insulin injections to control the disease. This and the knowledge that type 2 diabetes is currently reaching epidemic proportions worldwide, prompted Bo Hjelt, together with his wife Kerstin, to create a Foundation.
Approximately EUR 90’000 – is annually attributed to Geneva and Lund Universities for Fellowships: Each receiving EUR 45’000. After reception of research applications from the two universities, a Scientific Advisory Board comprising Leif Groop, Claes Wollheim and Joachim Karsegard will establish a list of candidates to whom Fellowships should be attributed.
“It is an economic contribution of great importance to us for the diabetic research at Lund University Diabetes Center (LUDC)”, says Professor Leif Groop.